Titlebook: Applications of Biotechnology in Oncology; Kewal K. Jain Book 2014 Springer Science+Business Media New York 2014 Anticancer agents.Cancer

incoherent

書目名稱Applications of Biotechnology in Oncology影響因子(影響力)




書目名稱Applications of Biotechnology in Oncology影響因子(影響力)學(xué)科排名




書目名稱Applications of Biotechnology in Oncology網(wǎng)絡(luò)公開度




書目名稱Applications of Biotechnology in Oncology網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Applications of Biotechnology in Oncology被引頻次




書目名稱Applications of Biotechnology in Oncology被引頻次學(xué)科排名




書目名稱Applications of Biotechnology in Oncology年度引用




書目名稱Applications of Biotechnology in Oncology年度引用學(xué)科排名




書目名稱Applications of Biotechnology in Oncology讀者反饋




書目名稱Applications of Biotechnology in Oncology讀者反饋學(xué)科排名

檔案

乞討

Biomarkers of Cancer,teration of a cell on DNA, RNA, metabolite, or protein level can be referred to as a molecular biomarker. In the era of molecular biology, biomarkers usually mean molecular biomarkers and can be divided into three broad categories (Jain 2010):

jealousy

Book 2014terature on this topic and numerous tables and figures, .Applications of Biotechnology in Oncology. serves as an ideal reference for oncologists, scientists involved in research on cancer biology, and physicians in various specialties who deal with cancer.

DNR215

Firm Performance and Employee Relations, patients’ health. Oncogenomics has assumed importance as a guide to management and development of personalized cancer therapies. Gene expression profiling of tumors is also used for developing targeted anticancer therapies.

degradation

剝削

https://doi.org/10.1007/978-1-349-01784-3 a static snapshot of the various ways in which the cell might use its proteins, whereas the life of the cell is a dynamic process. With this background, DNA/RNA (ribonucleic acid) sequences, per se, are not enough for the clear identification of a therapeutic target because proteins and not DNA/RNA are the basis of mode of action of drugs.

intertwine

commensurate

Sequencing in Cancer,hnologies means determination of variations of DNA sequence in an organism where the nominal sequence is already known. It is often performed using PCR to amplify the region of interest (preexisting DNA sequence is required to design the PCR primers). Resequencing is more relevant for translation into diagnostics and clinical applications.

Cupping

Oncoproteomics, a static snapshot of the various ways in which the cell might use its proteins, whereas the life of the cell is a dynamic process. With this background, DNA/RNA (ribonucleic acid) sequences, per se, are not enough for the clear identification of a therapeutic target because proteins and not DNA/RNA are the basis of mode of action of drugs.